Bharat Biotech’s Covaxin shows 77.8% efficacy in phase III trials
New Delhi: Bharat Biotech’s Covaxin is 77.8 per cent effective in protecting against Covid-19, according to data from Phase III ...
Read moreNew Delhi: Bharat Biotech’s Covaxin is 77.8 per cent effective in protecting against Covid-19, according to data from Phase III ...
Read moreBhubaneswar: Odisha registered Tuesday 2,957 new Covid-19 cases, the lowest in the past two months. In fact that this is ...
Read moreNew Delhi: With no major domestic macroeconomic data to be released this week, the equity market trend will be determined ...
Read moreBhubaneswar: As many as 1.36 lakh healthcare workers registered for vaccination in the state have not taken vaccines so far. ...
Read moreLucknow: The Yogi Adityanath government will now send out invitation slips to people, urging them to get vaccinated. The invitation ...
Read moreNew Delhi: A government panel studying COVID-19 vaccine side effects has confirmed the first death due to anaphylaxis following vaccination. ...
Read moreBhubaneswar: Taking an initiative to vaccinate those seeking to fly abroad for higher studies, the Bhubaneswar Municipal Corporation (BMC) has prepared ...
Read moreIndia, like the rest of the world, is in the grip of a once in a century pandemic snuffing out ...
Read moreNew Delhi: The Centre said Tuesday it has placed orders for 44 crore doses of Covishield and Covaxin. This announcement ...
Read moreNew Delhi: Use of non-transferable electronic vouchers approved by the Reserve Bank of India (RBI) will be encouraged to enable ...
Read more